Advanced search
Publication Cover
Amyotrophic Lateral Sclerosis Volume 12, 2011 - Issue 6
Journal homepage
420
Views
10
CrossRef citations to date
0
Altmetric
Short Reports

The use of subcutaneous glycopyrrolate in the management of sialorrhoea and facilitating the use of non-invasive ventilation in amyotrophic lateral sclerosis

Johnathan Cooper-KnockAcademic Unit of Neurology, Sheffield Teaching Hospitals NHS Foundation TrustCorrespondence[email protected]
,
Sam H. AhmedzaiAcademic Unit of Supportive Care, University of Sheffield, Sheffield, UK
&
Pamela ShawAcademic Unit of Neurology, Sheffield Teaching Hospitals NHS Foundation Trust
Pages 464-465 | Received 23 Feb 2011, Accepted 21 Apr 2011, Published online: 09 May 2011

References

  • Miller RG, Jackson CE, Kasarskis EJ, England JD, Forshew D, Johnston W, . Practice Parameter update. The care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioural impairment (an evidence-based review). Neurology. 2009; 73:1227–33.
  • Hadjikoutis S, Wiles CM. Respiratory complications related to bulbar dysfunction in motor neuron disease. Acta Neurologica Scandinavica. 2001;103:207–13.
  • Bourke SC, Tomlinson M, Williams TL, Bullock RE, Shaw PJ, Gibson GJ. Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomized controlled trial. The Lancet Neurology. 2006;5:140–7.
  • Andersen PM, Borasio GD, Dengler R, Hardiman O, Kollewe K, Leigh PN, . Good practice in the management of amyotrophic lateral sclerosis: clinical guidelines. An evidence based review with good practice points. EALSC Working Group. Amyotroph Lateral Scler. 2007;8:195–213.
  • Mirakhur RK, Dundee JW. Comparison of the effects of atropine and glycopyrrolate on various end-organs. J R Soc Med. 1980;73:727–30.
  • Arbouw MEL, Movig KLL, Koopmann M, Poels PJE, Guchelaar H-J, Egberts TCG, . Glycopyrrolate for sialorrhoea in Parkinson's disease. Neurology. 2010; 74:1203–7.
  • Fuder H, Meincke M. Glycopyrronium bromide blocks differentially responses mediated by muscarinic receptor subtypes. Naunyn Schmiedebergs Arch Pharmacol. 1993;347:591–5.
  • Strutt R, Fardell B, Chye R. Nebulized glycopyrrolate for drooling in a motor neuron patient. Journal of Pain and Symptom Management. 2002;23:2–3.
  • Jackson CE, Gronseth G, Rosenfeld J, Barohn RJ, Dubinsky R, Simpson CB, . Randomized double-blind study of botulinum toxin type B for sialorrhoea in ALS patients. Muscle & Nerve. 2009;39:137–43.
  • Dogu O, Apaydin D, Sevim S, Talas DU, Aral M. Ultrasound-guided versus ‘blind’ intraparotid injections of botulinum toxin-A for the treatment of sialorrhoea in patients with Parkinson's disease. Clinical Neurology and Neurosurgery. 2004;106:93–6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.